External Quality Assurance of Malaria Nucleic Acid Testing for Clinical Trials and Eradication Surveillance

• Sean C. Murphy ,

  * E-mail: murphysc@uw.edu

  Affiliation Department of Laboratory Medicine and Center for Emerging and Re-Emerging Infectious Diseases, University of Washington (UW), Seattle, Washington, United States of America

  ⨯
• Cornelus C. Hermsen,

  Affiliation Department of Medical Microbiology, Radboud University Medical Center (RUMC), Nijmegen, The Netherlands

  ⨯
• Alexander D. Douglas,

  Affiliation The Jenner Institute, University of Oxford, Oxford, United Kingdom

  ⨯
• Nick J. Edwards,

  Affiliation The Jenner Institute, University of Oxford, Oxford, United Kingdom

  ⨯
• Ines Petersen,

  Affiliation European Vaccine Initiative (EVI), Heidelberg, Germany

  ⨯
• Gary A. Fahle,

  Affiliation Department of Laboratory Medicine, Clinical Center, National Institutes of Health (NIH), Bethesda, Maryland, United States of America

  ⨯
• Matthew Adams,

  Affiliation Center for Vaccine Development and Howard Hughes Medical Institute, University of Maryland School of Medicine, Baltimore, Maryland, United States of America

  ⨯
• Andrea A. Berry,

  Affiliation Center for Vaccine Development and Howard Hughes Medical Institute, University of Maryland School of Medicine, Baltimore, Maryland, United States of America

  ⨯
• Zachary P. Billman,

  Affiliation Department of Laboratory Medicine and Center for Emerging and Re-Emerging Infectious Diseases, University of Washington (UW), Seattle, Washington, United States of America

  ⨯
• Sarah C. Gilbert,

  Affiliation The Jenner Institute, University of Oxford, Oxford, United Kingdom

  ⨯
• Matthew B. Laurens,

  Affiliation Center for Vaccine Development and Howard Hughes Medical Institute, University of Maryland School of Medicine, Baltimore, Maryland, United States of America

  ⨯
• Odile Leroy,

  Affiliation European Vaccine Initiative (EVI), Heidelberg, Germany

  ⨯
• Kristen E. Lyke,

  Affiliation Center for Vaccine Development and Howard Hughes Medical Institute, University of Maryland School of Medicine, Baltimore, Maryland, United States of America

  ⨯
• Christopher V. Plowe,

  Affiliation Center for Vaccine Development and Howard Hughes Medical Institute, University of Maryland School of Medicine, Baltimore, Maryland, United States of America

  ⨯
• Annette M. Seilie,

  Affiliation Department of Laboratory Medicine and Center for Emerging and Re-Emerging Infectious Diseases, University of Washington (UW), Seattle, Washington, United States of America

  ⨯
• Kathleen A. Strauss,

  Affiliation Center for Vaccine Development and Howard Hughes Medical Institute, University of Maryland School of Medicine, Baltimore, Maryland, United States of America

  ⨯
• Karina Teelen,

  Affiliation Department of Medical Microbiology, Radboud University Medical Center (RUMC), Nijmegen, The Netherlands

  ⨯
• Adrian V. S. Hill,

  Affiliation The Jenner Institute, University of Oxford, Oxford, United Kingdom

  ⨯
•  [ ... ],
• Robert W. Sauerwein

  Affiliation Department of Medical Microbiology, Radboud University Medical Center (RUMC), Nijmegen, The Netherlands

  ⨯
• [ view all ]
• [ view less ]